1
HIV/AIDS: A Global Health Challenge in the Modern Era
Student’s Name
Institution
Course
Instructor
Date
2
HIV/AIDS: A Global Health Challenge in the Modern Era
This paper compares and contrasts the present approaches to HIV diagnosis, antiretroviral
treatments, and prevention techniques such as PrEP, as well as research on HIV vaccines.
Through exploring these factors, we also stress the need for further investigation and
international collaboration, as well as the need to employ multifaceted strategies for combating
HIV/AIDS.
History and First Identification
The HIV/AIDS disease was discovered in the early 1980s when cases of rare
opportunistic infections and cancers, which were common in immune-compromised patients,
were noted in previously healthy, young men of similar sexual orientation in big cities in the
USA (Justiz & Gulick, 2022). In August 1983, Dr. Luc Montagnier at Pasteur Institute in France
reported the presence of a new virus he discovered in an AIDS patient, which was christened
Human Immunodeficiency Virus (HIV). The association between HIV and AIDS was made in
1984 by Robert Gallo at the National Cancer Institute in the US (Waymack & Sundareshan,
2019).
Incidence
Recent literature has reported on the worldwide prevalence of HIV/AIDS as a pressing
issue. Although general worldwide estimates remain rough, regional research provides insight
into current struggles. In one piece of research regarding various districts in Nanning, China, for
instance, the trends in the prevalence of HIV were shown to differ and thus require measures of
prevention that would also be similarly specific (Cen et al., 2024).
Pathogenesis
3
HIV is a type of retrovirus that primarily infects CD4+ T lymphocytes, believed to be
essential components of the human body's immune system. The virus enters these cells through
the CD4 receptor and co-receptors, usually CCR5 or CXCR4(Justiz & Gulick, 2022). Inside the
cell, HIV then integrates its DNA into the host cell DNA and begins the production of new virus
particles. This eventually leads, over time, through such a selective process, to the loss of the
CD4+ T cells, thereby compromising the immune system, and unless treated, this leads finally to
AIDS (Justiz & Gulick, 2022).
Clinical Manifestations
HIV infection progresses through four stages: First is an acute infection with influenza-
like symptoms; second is a chronic asymptomatic infection which may take years; third is
symptomatic HIV when the immune system is compromised; and fourth is AIDS, as defined by
low CD4 count or HIV-related disease. Weight loss, fever, night sweats, and recurrent infections
characterise the terminal phases. If left untreated, the disease progresses from primary infection
to AIDS and the immune system is severely and progressively damaged (Waymack &
Sundareshan, 2019).
Complications
Common complications include:
1. Pneumocystis pneumonia
2. Kaposi's sarcoma
3. Tuberculosis
4. Lymphomas
4
Etiology
HIV is a type of lentivirus, which is a subgroup of retroviruses. There are two types:
HIV-1 and HIV-2, the former being responsible for the vast majority of infections globally. HIV-
1 is believed to have originated from SIV amongst non-human primates due to a zoonotic
passage to humans in the early part of the 20th century (Waymack & Sundareshan, 2019).
Epidemiology
Global HIV/AIDS prevalence is not equal across the world for different regions and
populations. Within the developing world, sub-Saharan Africa suffers the most, hosting roughly
two-thirds of global HIV infection. High-risk should target populations such as MSM, people
who use drugs, SWs, and transgender people or cross-dressers. The social, economic as well as
biological structure of women and girls makes them more vulnerable. Other studies, like the one
conducted in Nanning, China, have also emphasized that the different local epidemiological
patterns should be considered when designing community-specific prevention strategies (Cen et
al., 2024). This approach facilitates a more effective distribution of resources and individualized
efforts to stop the transmission of HIV in particular settings.
Diagnostic Test
HIV diagnosis involves a combination of tests:
Antibody/antigen tests: Detect HIV antibodies and the p24 antigen.
Nucleic acid tests (NAT): Detect the presence of HIV genetic material.
Western blot or immunofluorescence assay: Used as confirmatory tests.
5
CD4 count and viral load tests: Monitor disease progression and treatment effectiveness
(Justiz & Gulick, 2022).
Treatment
ART turned HIV from a life-threatening diagnosis into a chronic disease. Currently, most
ART regimens combine at least three antiretroviral drugs from no less than two classes of drugs.
The most common drug classes include:
Nucleoside reverse transcriptase inhibitors (NRTIs)
NNRTIs, or non-nucleoside reverse transcriptase inhibitors
Protease inhibitors;
INIs (integrase inhibitors) (Waymack & Sundareshan, 2019).
Vaccination
There is no licensed vaccine available for the prevention of HIV infection. The
development of an effective vaccine against HIV is complex because the virus has a high rate of
mutation and thus often evades host immune responses. However, several candidate vaccines are
in various stages of clinical trials. Recent progress in broadly neutralizing antibodies and mRNA
vaccine technology has restored hope for a hopefully successful HIV vaccine (Justiz & Gulick,
2022).
6
Prevention and Control Measures
Behavioural, biomedical, and structural approaches constitute HIV prevention. The
strategies range from advocating for safe sexual practices to harm reduction for injecting drug
users. From the biomedical perspective, they include preexposure prophylaxis (PrEP),
postexposure prophylaxis (PEP), and treatment as prevention (TasP) (Cen et al., 2024). Other
key strategies include prevention of mother-to-child transmission programs, voluntary medical
male circumcision in high-prevalence settings, comprehensive sexuality education, and
addressing social and structural drivers of HIV transmission. Recent studies emphasize that such
strategies must be targeted at the local context if they are genuinely effective (Cen et al., 2024).
Public Health Significance
HIV/AIDS is still a critical public health issue that continues to have social, economic
and public health consequences. It has impacted more than the other population groups and
worsened the health inequalities. The HIV epidemic has also pointed out the need to eliminate
prejudice and discrimination in the provision of care and the world (Waymack & Sundareshan,
2019).
The UNAIDS 95-95-95 targets, which hope to reduce AIDS to a manageable problem by 2030,
include 95% of people with HIV having a correct and accurate diagnosis through a test, 95% of
diagnosed people accessing ART, and 95% of ART users maintaining viral suppression. Further
political commitment is necessary to achieve these goals, with increased funding for research and
programs and the introduction of innovative prevention, treatment, and care models (Cen et al.,
2024).
7
References
8
Cen, P., Xu, G., Wu, J., Qin, J., He, J., Deng, X., Yang, X., Lu, P., Nong, M., Jiang, J., Ye, L.,
Tang, H., Liang, B., & Liang, H. (2024). Effectiveness of human immunodeficiency virus
prevention strategies by mapping the geographic dispersion pattern of human
immunodeficiency virus prevalence in Nanning, China: BMC Public Health. *BMC
Public Health*, *24*(1), 1–11. https://doi.org/10.1186/s12889-024-18345-9
Justiz, A. A., & Gulick, P. G. (2022). *HIV and AIDS syndrome*. Nih.gov; StatPearls
Publishing. https://www.ncbi.nlm.nih.gov/books/NBK534860/
Waymack, J. R., & Sundareshan, V. (2019, June 16). *Acquired Immune Deficiency Syndrome
(AIDS)*. Nih.gov; StatPearls Publishing.
https://www.ncbi.nlm.nih.gov/books/NBK537293/
